The FDA has expanded the approved indication of IV Avtozma to include the treatment of CRS in patients 2 years of age and older.

Injection of hProCA32.collagen contrast agent resulted in 60 and 80.5% enhancement at 3 h time point compared with pre-injection for the early and late stage of IPF mice, respectively, while injection ...

To minimize contrast use, she underwent ultra-low contrast PCI using the “microcatheter injection” technique, with only 5 cc of contrast used during the procedure. At one-year follow-up, the patient's ...